Claims for Patent: 5,618,697

✉ Email this page to a colleague

Summary for Patent: 5,618,697

Title:	Process for preparing a desired protein
Abstract:	A process for producing ripe human growth hormone is described which comprises introducing into bacteria a recombinant DNA vector comprising a DNA sequence encoding an amino-terminal extended human growth hormone which amino-terminal extension has a negatively charged amino acid sequence and has an even number of amino acids, growing the bacteria such that the amino-terminal extended human growth is expressed, separating the amino-terminal extended human grown hormone from contaminants, cleaving the amino-terminal extension with dipeptidyl aminopeptidase I to obtain ripe human growth hormone and isolating the ripe human growth hormone produced.
Inventor(s):	Henrik Dalb.o slashed.ge, John Pedersen, Thorkild Christensen, J.o slashed.rli W. Ringsted, Torben E. Jessen
Assignee:	Novo Nordisk Health Care AG
Application Number:	US08/372,692
Patent Claims:

Details for Patent 5,618,697

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	June 20, 2000	⤷ Get Started Free	2015-01-13
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	October 01, 2004	⤷ Get Started Free	2015-01-13
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	March 10, 2009	⤷ Get Started Free	2015-01-13
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	March 01, 2010	⤷ Get Started Free	2015-01-13
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	January 23, 2015	⤷ Get Started Free	2015-01-13
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 5,618,697

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	8604609	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	8402351	⤷ Get Started Free
United States of America	5691169	⤷ Get Started Free
United States of America	5679552	⤷ Get Started Free
United States of America	5635604	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.